These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8278307)

  • 41. A pharmacokinetic study of the active metabolite of nabumetone in young healthy subjects and older arthritis patients.
    Kendall MJ; Chellingsworth MC; Jubb R; Thawley AR; Undre NA; Kill DC
    Eur J Clin Pharmacol; 1989; 36(3):299-305. PubMed ID: 2744071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of the clinical pharmacokinetics of nabumetone.
    Hyneck ML
    J Rheumatol Suppl; 1992 Nov; 36():20-4. PubMed ID: 1474531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of enterohepatic circulation of the active metabolite of nabumetone in humans.
    Brett MA; Buscher G; Ellrich E; Greb WH; Kurth HJ; Rülander G; Schmerenbeck B; Haddock R; Thawley A
    J Rheumatol Suppl; 1992 Nov; 36():81-2. PubMed ID: 1474541
    [No Abstract]   [Full Text] [Related]  

  • 44. Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.
    Hand WL; Butera ML; King-Thompson NL; Hand DL
    Infect Immun; 1989 Nov; 57(11):3520-6. PubMed ID: 2553608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of carbonyl reducing enzymes in the phase I biotransformation of the non-steroidal anti-inflammatory drug nabumetone in vitro.
    Skarydova L; Nobilis M; Wsól V
    Xenobiotica; 2013 Apr; 43(4):346-54. PubMed ID: 23020786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nabumetone. Evidence for the lack of enterohepatic circulation of the active metabolite 6-MNA in humans.
    Brett MA; Buscher G; Ellrich E; Greb WH; Kurth HJ; Rülander G; Schmerenbeck B; Haddock RE; Thawley AR
    Drugs; 1990; 40 Suppl 5():67-70. PubMed ID: 2081498
    [No Abstract]   [Full Text] [Related]  

  • 47. [Determination of nabumetone and 6-methoxy-2-naphthylacetic acid in plasma using HPLC with UV and MS detection].
    Nespesná L; Stícha M; Matousková O; Perlík F; Slanar O
    Ceska Slov Farm; 2011 Feb; 60(1):17-24. PubMed ID: 21650014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbon-carbon bond cleavage in activation of the prodrug nabumetone.
    Varfaj F; Zulkifli SN; Park HG; Challinor VL; De Voss JJ; Ortiz de Montellano PR
    Drug Metab Dispos; 2014 May; 42(5):828-38. PubMed ID: 24584631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nabumetone--a novel anti-inflammatory drug: bioavailability after different dosage regimens.
    von Schrader HW; Buscher G; Dierdorf D; Mügge H; Wolf D
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):672-6. PubMed ID: 6526543
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Staphylococcal delta toxin-induced generation of chemiluminescence by human polymorphonuclear leukocytes.
    Tomita T; Momoi K; Kanegasaki S
    Toxicon; 1984; 22(6):957-65. PubMed ID: 6441313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous determination of nabumetone and its principal metabolite in medicines and human urine by time-resolved fluorescence.
    Murillo Pulgarín JA; Alañón Molina A; Martínez Ferreras F
    Analyst; 2012 Nov; 137(21):5144-52. PubMed ID: 22977877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Penetration of nabumetone into inflammatory exudates in the rat.
    Haddock RE; Jeffery DJ; Mangan FR; Pardon IS
    J Pharm Pharmacol; 1983 Jun; 35(6):358-62. PubMed ID: 6135773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Murexide bleaching: a new direct assay method for characterizing reactive oxygen species.
    Torreilles J; Guerin MC; Carrie ML
    Biochimie; 1989; 71(11-12):1231-4. PubMed ID: 2561347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut microbiota metabolizes nabumetone
    Jourova L; Anzenbacher P; Matuskova Z; Vecera R; Strojil J; Kolar M; Nobilis M; Hermanova P; Hudcovic T; Kozakova H; Kverka M; Anzenbacherova E
    Xenobiotica; 2019 Nov; 49(11):1296-1302. PubMed ID: 30794062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nabumetone (BRL 14777) presystemic elimination and disposition in patients with liver impairments.
    Terziivanov D; Maleev A; Vlahov V
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):208-13. PubMed ID: 2884189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radical scavenger activity of bendazac, an anticataract non-steroidal anti-inflammatory agent.
    Guglielmotti A; Capezzone De Joannon A; Cazzolla N; Marchetti M; Soldo L; Cavallo G; Pinza M
    Pharmacol Res; 1995 Dec; 32(6):369-73. PubMed ID: 8736488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Simplex optimization of the variables affecting the micelle-stabilized room temperature phosphorescence of 6-methoxy-2-naphthylacetic acid and its kinetic determination in human urine.
    Pulgarín JA; Molina AA; Pardo MT
    Anal Biochem; 2005 Apr; 339(1):157-64. PubMed ID: 15766723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of 6-Methoxy-2-Naphthylacetic Acid (6MNA), the Active Metabolite of Nabumetone, on the Glycosaminoglycan Synthesis of Canine Articular Cartilage In Vitro : Comparison with Other Nonsteroidal Anti-Inflammatory Drugs.
    Gentry C; Blower P; Spangler R
    Clin Drug Investig; 1995 Dec; 10(6):355-64. PubMed ID: 27519337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymorphonuclear leukocyte mediated oxidative inactivation of alpha-1-proteinase inhibitor: Modulation by nitric oxide.
    Mir MM; Khan AR; Dar NA; Salahuddin M
    Indian J Clin Biochem; 2005 Jan; 20(1):184-92. PubMed ID: 23105520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applicability of LC/MS/MS assay for 6-methoxy-2-napthylacetic acid to support the bioequivalence study of nabumetone-comments on the research work of Patel et al. (2008).
    Srinivas NR
    Biomed Chromatogr; 2009 Jun; 23(6):674-5. PubMed ID: 19277989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.